IP Library Granted Patent US 8,652,417
Granted Patent B2
US 8,652,417 · App. 13/010,298 · Granted Feb 18, 2014

Crystallization media

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,652,417
App. No.
13/010,298
Granted
Feb 18, 2014
Kind
B2
Abstract

A set of crystallization solutions includes a plurality of crystallization solutions of Crystallization Solution Set I, a plurality of crystallization solutions of Crystallization Solution Set II or a plurality of crystallization solutions of Crystallization Solution Set III.

Claims (58)

1. A set of crystallization solutions comprising a plurality of crystallization solutions of Crystallization Solution Set II

wherein the Crystallization Solution Set II consists of:

(1) A1 containing 0.3 M ammonium chloride, 0.1 M citric acid, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 4,

(2) A2 containing 0.3 M ammonium formate, 0.1 M potassium nitrate, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 6.6,

(3) B1 containing 0.3 M ammonium nitrate, 0.1 M sodium citrate tribasic dihydrate, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 5.9,

(4) B2 containing 0.3 M ammonium phosphate monobasic, 0.1 M MES monohydrate, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 5.7,

(5) C1 containing 0.3 M ammonium sulfate, 0.1 M BIS-TRIS, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 6.8,

(6) C2 containing 0.3 M di-ammonium tartrate, 0.1 M sodium acetate trihydrate, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 5.8,

(7) D1 containing 0.3 M cadmium chloride, 0.1 M sodium acetate trihydrate, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 3.7,

(8) D2 containing 0.3 M cadmium sulfate, 0.1 M imidazole, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 4.6,

(9) E1 containing 0.3 M caesium chloride, 0.1 M HEPES, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 7.6,

(10) E2 containing 0.3 M calcium acetate, 0.1 M BICINE, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 6.4,

(11) F1 containing 0.3 M calcium chloride, 0.1 M BIS-TRIS propane, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 8.5,

(12) F2 containing 0.3 M cobalt(II) chloride hexahydrate, 0.1 M ammonium citrate, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 3.2,

(13) G1 containing 0.3 M di-ammonium hydrogen citrate, 0.1 M magnesium formate, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 4.9,

(14) G2 containing 0.3 M DL-malic acid, 0.1 M sodium cacodylate trihydrate, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 2.9,

(15) H1 containing 0.3 M iron(III) chloride hexahydrate, 0.1 M potassium nitrate, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 1.1,

(16) H2 containing 0.3 M lithium chloride, 0.1 M potassium formate, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 6.3,

(17) A6 containing 0.3 M lithium sulfate monohydrate, 0.1 M CHES, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 9.5,

(18) A7 containing 0.3 M magnesium acetate tetrahydrate, 0.1 M citric acid, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 4.7,

(19) B6 containing 0.3 M magnesium chloride hexahydrate, 0.1 M sodium cacodylate trihydrate, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 5.8,

(20) B7 containing 0.3 M magnesium nitrate hexahydrate, 0.1 M HEPES, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 7.4,

(21) C6 containing 0.3 M magnesium sulfate heptahydrate, 0.1 M potassium formate, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 6.1,

(22) C7 containing 0.3 M nickel(II) chloride hexahydrate, 0.1 M MES monohydrate, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 5.7,

(23) D6 containing 0.3 M potassium bromide, 0.1 M BIS-TRIS, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 6.6,

(24) D7 containing 0.3 M potassium phosphate monobasic, 0.1 M Tris, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 6.1,

(25) E6 containing 0.3 M potassium sodium tartrate tetrahydrate, 0.1 M BICINE, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 8.8,

(26) E7 containing 0.3 M potassium tartrate, 0.1 M imidazole, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 7.3,

(27) F6 containing 0.3 M potassium thiocyanate, 0.1 M ammonium citrate, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 5.8,

(28) F7 containing 0.3 M sodium bromide, 0.1 M sodium cacodylate trihydrate, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 6.5,

(29) G6 containing 0.3 M sodium chloride, 0.1 M Tris, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 8.1,

(30) G7 containing 0.3 M sodium fluoride, 0.1 M CHES, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 9.6,

(31) H6 containing 0.3 M sodium formate, 0.1 M citric acid, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 4.5,

(32) H7 containing 0.3 M sodium iodide, 0.1 M sodium acetate trihydrate, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 4.7,

(33) A11 containing 0.3 M sodium malonate, 0.1 M sodium citrate tribasic dihydrate, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 6.8,

(34) A12 containing 0.3 M sodium nitrate, 0.1 M MES monohydrate, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 6.1,

(35) B11 containing 0.3 M sodium phosphate monobasic monohydrate, 0.1 M BIS-TRIS, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 5.8,

(36) B12 containing 0.3 M sodium sulfate, 0.1 M BIS-TRIS propane, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 9.3,

(37) C11 containing 0.3 M sodium thiocyanate, 0.1 M HEPES, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 7.8,

(38) C12 containing 0.3 M succinic acid, 0.1 M imidazole, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 3.4,

(39) D11 containing 0.3 M tri-methylamine N-oxide, 0.1 M BICINE, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 8.6,

(40) D12 containing 0.3 M tri-potassium citrate, 0.1 M BIS-TRIS propane, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 9.8,

(41) E11 containing 10% Jeffamine M-600, 0.1 M HEPES, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 7.5,

(42) E12 containing 0.3 M zinc chloride, 0.1 M magnesium formate, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 5.7,

(43) F11 containing 0.3 M zinc sulfate heptahydrate, 0.1 M sodium citrate tribasic dihydrate, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 4,

(44) F12 containing 0.1 M CHES, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 9.9,

(45) G11 containing 0.1 M imidazole, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 6.6,

(46) G12 containing 0.1 M magnesium formate, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 5.9,

(47) H11 containing 0.1 M sodium acetate trihydrate, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 4.7, and

(48) H12 containing 0.1 M Tris, 22.5% PolyPure PEG 0.3-10 kD and having a pH of 8.1.

2. The set of crystallization solutions of claim 1 , wherein the set of crystallization solutions comprises at least 5 of the crystallization solutions of Crystallization Solution Set II.

3. The set of crystallization solutions of claim 1 , wherein the set of crystallization solutions comprises at least 2 of the crystallization solutions of Crystallization Solution Set II with different concentration of polymer.

4. The set of crystallization solutions of claim 1 , wherein the set of crystallization solutions comprises at least 2 of the crystallization solutions of Crystallization Solution Set II with different concentration of salt.

5. The set of crystallization solutions of claim 1 , wherein the set of crystallization solutions comprises at least 2 of the crystallization solutions of Crystallization Solution Set II with different types of salt.

6. The set of crystallization solutions of claim 1 , wherein the set of crystallization solutions comprises at least 2 of the crystallization solutions of Crystallization Solution Set II with different buffers.

7. The set of crystallization solutions of claim 1 , wherein the set of crystallization solutions comprises at least 2 of the crystallization solutions of Crystallization Solution Set II with different concentration of buffers.

8. The set of crystallization solutions of claim 1 , wherein the set of crystallization solutions comprises at least 2 of the crystallization solutions of Crystallization Solution Set II and is suitable for liquid-liquid protein crystallization.

9. A kit comprising at least one crystallization device and a set of crystallization solutions according to claim 1 .

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Jun 10, 2020
From: LBC CREDIT AGENCY SERVICES, LLC, AS AGENT
To: ANATRACE PRODUCTS, LLC
Reel/Frame 052896/0295 →
SECURITY INTEREST Recorded Jun 10, 2020
From: ALPHA-TEC SYSTEMS, INC.; ANATRACE PRODUCTS, LLC; EDGE BIOSYSTEMS, INC.; MOLECULAR DIMENSIONS, INC.
To: CVC CREDIT PARTNERS, LLC
Reel/Frame 052896/0983 →
RELEASE OF SECURITY INTEREST Recorded Jul 17, 2017
From: OPUS BANK
To: ANATRACE PRODUCTS, LLC; EDGE BIOSYSTEMS, INC.
Reel/Frame 043026/0351 →
RELEASE OF SECURITY INTEREST Recorded Jul 17, 2017
From: FIDUS MEZZANINE CAPITAL, L.P.
To: ANATRACE PRODUCTS, LLC; EDGE BIOSYSTEMS, INC.
Reel/Frame 043026/0361 →
SECURITY INTEREST Recorded Jul 14, 2017
From: ANATRACE PRODUCTS, LLC
To: LBC CREDIT AGENCY SERVICES, LLC, AS AGENT
Reel/Frame 043008/0364 →
SECURITY INTEREST Recorded Dec 30, 2015
From: EDGE BIOSYSTEMS, INC.; ANATRACE PRODUCTS, LLC
To: FIDUS MEZZANINE CAPITAL, L.P.
Reel/Frame 037380/0659 →
PATENT SECURITY AGREEMENT Recorded Dec 29, 2015
From: EDGE BIOSYSTEMS, INC.; ANATRACE PRODUCTS, LLC
To: OPUS BANK
Reel/Frame 037396/0638 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2015
From: MICROLYTIC NORTH AMERICA, INC.
To: ANATRACE PRODUCTS, LLC
Reel/Frame 036028/0615 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2015
From: MICROLYTICS APS
To: MICROLYTIC NORTH AMERICA INC.
Reel/Frame 034642/0383 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2011
From: SOMMER, MORTEN
To: MICROLYTIC APS
Reel/Frame 025832/0835 →